Type

Journal Article

New treatments for serious conditions: ethical implications

View online source

Authors:

Nancy M.P. King

Colin Edward Bishop

Year:

2017

Gene Therapy

Return to Search Results

Share

Related Publications

Journal Article

Who is responsible for promoting equity in rare disease research?
Journal Article

Equitable access to gene therapy: A call to action for the American Society of Gene and Cell Therapy
Journal Article

Patient and family social media use surrounding a novel treatment for a rare genetic disease: A qualitative interview study
Journal Article

Gene therapy: evidence, value and affordability in the US health care system
Journal Article

Addressing the value of gene therapy and enhancing patient access to transformative treatments
Journal Article

The Landscape of Cellular and Gene Therapy Products: Authorization, Discontinuations, and Cost
Journal Article

The potential price and access implications of the cost-utility and budget impact methodologies applied by NICE in England and ICER in the US for a novel gene therapy in Parkinson's disease
Journal Article

Gene therapies: The challenge of super-high-cost treatments and how to pay for them
Journal Article

Value-based pricing for emerging gene therapies: The economic case for a higher cost-effectiveness threshold
Journal Article

CRISPR democracy: Gene editing and the need for inclusive deliberation
Journal Article

Gene therapy of hemoglobinopathies: progress and future challenges
Journal Article

Regeneration X: The payer perspective on gene therapy
Book Chapter

Issues and ethical considerations in pharmaco-oncogenomics
Journal Article

Overcoming challenges facing advanced therapies in the EU market

+